|
The
following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive
based on the application of the treasury stock method and because the Company incurred net losses during the period:
SCHEDULE OF ANTI DILUTIVE SECURITIES
| |
|
2024 |
|
|
2023 |
|
| |
|
Years Ended December 31, |
|
| |
|
2024 |
|
|
2023 |
|
| Convertible notes payable |
|
|
516,105 |
|
|
|
365,274 |
|
| Preferred shares |
|
|
301,900 |
|
|
|
- |
|
| Restricted stock units |
|
|
49,704 |
|
|
|
17,178 |
|
| Warrants to purchase shares of common stock |
|
|
1,100 |
|
|
|
78,000 |
|
| Total potentially dilutive shares |
|
|
868,809 |
|
|
|
460,452 |
|
|